We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Simmons First National
SFNC
$3.46B
| $589K | ﹤0.01% |
26,560
+2,800
| +12% | +$65.5K |
|
1227
Hillman Solutions
HLMN
$1.71B
| $585K | ﹤0.01% |
60,100
+3,900
| +7% | +$41.7K |
|
|
AKRO
1228
DELISTED
Akero Therapeutics
AKRO
| $584K | ﹤0.01% |
21,000
+1,000
| +5% | +$30.3K |
|
1229
Enovis
ENOV
$1.48B
| $584K | ﹤0.01% |
13,317
+2,800
| +27% | +$123K |
|
1230
Vera Therapeutics
VERA
$2.08B
| $584K | ﹤0.01% |
13,800
| – | – |
|
1231
Edgewise Therapeutics
EWTX
$4.69B
| $582K | ﹤0.01% |
+21,800
| New | +$694K |
|
1232
BancFirst
BANF
$3.89B
| $581K | ﹤0.01% |
4,958
+700
| +16% | +$82.1K |
|
1233
MaxLinear
MXL
$6.95B
| $580K | ﹤0.01% |
29,281
+9,200
| +46% | +$148K |
|
1234
Freedom Holding
FRHC
$9.35B
| $575K | ﹤0.01% |
4,400
+700
| +19% | +$80.4K |
|
1235
John Wiley & Sons Class A
WLY
$2.63B
| $574K | ﹤0.01% |
13,137
+2,100
| +19% | +$103K |
|
1236
Coeur Mining
CDE
$19B
| $573K | ﹤0.01% |
+100,200
| New | +$649K |
|
|
BWIN
1237
Baldwin Insurance Group
BWIN
$2.99B
| $570K | ﹤0.01% |
14,700
+2,200
| +18% | +$103K |
|
1238
Clear Secure
YOU
$4.7B
| $567K | ﹤0.01% |
21,300
-3,500
| -14% | -$106K |
|
1239
MYR Group
MYRG
$5.1B
| $565K | ﹤0.01% |
3,800
+1,000
| +36% | +$140K |
|
1240
Brighthouse Financial
BHF
$3.42B
| $562K | ﹤0.01% |
11,700
| – | – |
|
1241
Silicon Motion
SIMO
$8.45B
| $562K | ﹤0.01% |
10,400
+100
| +1% | +$5.6K |
|
1242
Cohen & Steers
CNS
$4.4B
| $559K | ﹤0.01% |
6,051
| – | – |
|
1243
Strategic Education
STRA
$1.86B
| $557K | ﹤0.01% |
5,960
+900
| +18% | +$84K |
|
1244
Buckle
BKE
$2.31B
| $554K | ﹤0.01% |
10,900
+2,200
| +25% | +$104K |
|
1245
Carter's
CRI
$1.44B
| $554K | ﹤0.01% |
10,230
-1,300
| -11% | -$74.5K |
|
1246
Century Communities
CCS
$2.04B
| $550K | ﹤0.01% |
7,500
+1,400
| +23% | +$125K |
|
1247
HNI Corp
HNI
$3.56B
| $550K | ﹤0.01% |
10,926
+1,200
| +12% | +$64.4K |
|
|
FL
1248
DELISTED
Foot Locker
FL
| $548K | ﹤0.01% |
25,200
| – | – |
|
1249
Bankunited
BKU
$3.41B
| $547K | ﹤0.01% |
14,332
+900
| +7% | +$34.6K |
|
1250
Kornit Digital
KRNT
$827M
| $546K | ﹤0.01% |
17,657
+1,000
| +6% | +$28.7K |
|
Similar funds
GAM
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.